This bill sets a strict spending cap of $115,193,000 for the Health Resources and Services Administration's (HRSA) Health Care Systems program in fiscal year 2024. It directly affects federal funding for HRSA's healthcare programs that support underserved communities, including rural clinics and community health centers. The key provision is a legal limit preventing any increase above this specific amount for the designated program. This is a budgetary restriction, not a new policy or program.
This bill limits FY2024 funding for the Health Resources and Services Administration for the Ryan White HIV/AIDS Program. (This program provides federal funds to eligible metropolitan areas, states, and local community-based organizations to assist with health care costs and support services for individuals and families affected by HIV/AIDS.)
This bill sets a strict annual spending cap of $1.909 billion for the National Institutes of Health (NIH) Office of the Director for fiscal year 2024. It directly affects the NIH Office of the Director by limiting its available funds to this specific amount, overriding any other funding provisions. The key mechanism is a direct dollar limit on appropriations, preventing the use of funds beyond this threshold for the specified NIH office. This is a procedural budgetary restriction, not a policy change affecting public programs or services.
This bill sets a spending limit of $162.99 million for the National Institute of Nursing Research (NINR) within the National Institutes of Health (NIH) for fiscal year 2024. It directly affects the NINR by restricting the amount of federal funds it can use during that fiscal year. The key mechanism is a specific dollar cap that prevents the NINR from accessing funds exceeding this amount, regardless of other funding authorizations. The bill does not alter NINR programs or research priorities, only establishing a maximum budget level for FY2024.
This bill limits FY2024 funding for the National Center for Advancing Translational Sciences. (The center works with patient organizations, researchers, and clinicians to develop tools, technologies, and approaches to advance biomedical research and treatments.)
HR 1997 sets a funding cap of $441,997,000 for the National Library of Medicine (NLM) within the National Institutes of Health (NIH) for fiscal year 2024. This bill directly affects the NLM's budget allocation by limiting the total funds it can receive during that fiscal year. The provision prevents any additional funding beyond this specific amount, regardless of other existing laws or appropriations.
HR 1987 caps funding for the National Institute on Deafness and Other Communication Disorders (NIDCD) at $474.4 million for fiscal year 2024. This bill directly limits the available budget for the NIDCD, a division within the National Institutes of Health (NIH), preventing it from using more than this specified amount from federal funds during FY2024. The key mechanism is a statutory spending ceiling applied specifically to the NIDCD's appropriations. This is a procedural budgetary measure affecting only the institute's funding level, not its program requirements or research activities.
HR 1996 sets a maximum spending limit of $78,109,000 for the National Institutes of Health's John E. Fogarty International Center during fiscal year 2024. This bill directly affects the Fogarty Center's budget by restricting its available funds to this specific amount. The key provision is a statutory cap on appropriations, preventing the center from using more than the specified amount for its operations in FY2024. This is a procedural budgetary measure with no additional policy changes or program requirements.
This bill establishes a $3.49 billion spending cap for the National Heart, Lung, and Blood Institute (NHLBI) within the National Institutes of Health for fiscal year 2024. It directly limits the Department of Health and Human Services' available funding for NHLBI to this specific amount, preventing increases above the threshold. The provision applies exclusively to NHLBI's appropriations under the NIH, with no broader policy changes or additional mechanisms described.
HR 1995 imposes a spending cap of $314.68 million on the National Institute on Minority Health and Health Disparities (NIMHD) within the National Institutes of Health for fiscal year 2024. This bill directly affects the NIMHD by restricting its available funding to this specific amount, regardless of other authorizations. The key provision is a hard limit on federal funds for the institute’s operations and programs during FY2024. It does not alter the institute’s mission or create new policies, only sets a maximum funding level for that fiscal year.
HR 1994 sets a funding cap of $146,473,000 for the National Center for Complementary and Integrative Health (NCCIH) within the National Institutes of Health for fiscal year 2024. This bill directly affects the NCCIH by limiting the total funds it can access during FY2024, preventing it from exceeding this specific amount. The provision applies to funds authorized for the NCCIH and overrides any other law that might allow higher spending. It does not change the center's research focus or programs, only the maximum budget available. This is a procedural funding limitation, not a policy change to health care or research priorities.
This bill sets a spending limit for the National Cancer Institute within the Department of Health and Human Services for fiscal year 2024. It caps the total funds available to the institute at $5,743,892,000, preventing any amount above this figure from being used for that fiscal year. The provision directly affects the institute's ability to allocate resources for cancer research and related programs during the specified period. By establishing this financial ceiling, the legislation ensures that funding for the National Cancer Institute remains within a predetermined budgetary constraint.
